Oculus News
Print this Article | Send to Colleague
Oculus News
FDA Clearance for the New OCULUS Myopia Master®
The new OCULUS Myopia Master® has received the 510(k) clearance from the US Food and Drug Administration (FDA). Ushering in a new era, the OCULUS Myopia Master® is the world’s first device to combine the important measurement methods axial length, refraction values and the central corneal radii.
The quick, contactless and extremely accurate measurement method for axial length is not influenced by the accommodation-status of the eye and delivers reproducible results.
Thanks to the clever combination of measurements, the new Myopia Master® is so much more than just an auto-refractometer: the device opens new possibilities for eye care professionals in providing the best care for their patients.
The new Myopia Master® saves space and can be mounted on a workstation or an ophthalmic table. The software is operated directly via the inbuilt display.
"I am excited to use the only FDA cleared device that measures axial length, objective refraction and keratometry comfortably in just seconds. This small space-saving device has quickly become an indispensable tool in the management of patients in my practice." - Dr. William Tullo of Princeton Optometry
Find out more at www.myopia-master.com/us or contact your local OCULUS representative.
